DK129434B - Fremgangsmåde til fremstilling af et farmaceutisk præparat af acetylsalicylsyre som virksomt stof samt polysiloxan og en celluloseæter eller ester og med gradvis frigivelse af det virksomme stof. - Google Patents

Fremgangsmåde til fremstilling af et farmaceutisk præparat af acetylsalicylsyre som virksomt stof samt polysiloxan og en celluloseæter eller ester og med gradvis frigivelse af det virksomme stof.

Info

Publication number
DK129434B
DK129434B DK487571AA DK487571A DK129434B DK 129434 B DK129434 B DK 129434B DK 487571A A DK487571A A DK 487571AA DK 487571 A DK487571 A DK 487571A DK 129434 B DK129434 B DK 129434B
Authority
DK
Denmark
Prior art keywords
active substance
polysiloxane
ester
preparation
pharmaceutical composition
Prior art date
Application number
DK487571AA
Other languages
Danish (da)
English (en)
Other versions
DK129434C (OSRAM
Inventor
S Casadio
E Sclavi
R Perego
Original Assignee
Angeli Inst Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeli Inst Spa filed Critical Angeli Inst Spa
Publication of DK129434B publication Critical patent/DK129434B/da
Application granted granted Critical
Publication of DK129434C publication Critical patent/DK129434C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK487571AA 1970-10-09 1971-10-07 Fremgangsmåde til fremstilling af et farmaceutisk præparat af acetylsalicylsyre som virksomt stof samt polysiloxan og en celluloseæter eller ester og med gradvis frigivelse af det virksomme stof. DK129434B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4816770A GB1357737A (en) 1970-10-09 1970-10-09 Sustained release pharmaceutical compositions

Publications (2)

Publication Number Publication Date
DK129434B true DK129434B (da) 1974-10-14
DK129434C DK129434C (OSRAM) 1975-03-10

Family

ID=10447626

Family Applications (1)

Application Number Title Priority Date Filing Date
DK487571AA DK129434B (da) 1970-10-09 1971-10-07 Fremgangsmåde til fremstilling af et farmaceutisk præparat af acetylsalicylsyre som virksomt stof samt polysiloxan og en celluloseæter eller ester og med gradvis frigivelse af det virksomme stof.

Country Status (8)

Country Link
US (1) US3853988A (OSRAM)
CA (1) CA974883A (OSRAM)
DE (1) DE2149699A1 (OSRAM)
DK (1) DK129434B (OSRAM)
ES (1) ES395533A1 (OSRAM)
FR (1) FR2110314B1 (OSRAM)
GB (1) GB1357737A (OSRAM)
SE (1) SE382560B (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51123814A (en) * 1975-04-22 1976-10-28 Shin Etsu Chem Co Ltd A process for preparing gradually releasable solid medicines
US4167558A (en) 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
DE2902414A1 (de) * 1979-01-23 1980-08-07 Hoechst Ag Depotkoerper auf basis silicon- kautschuk sowie verfahren zu seiner herstellung
FR2514261B1 (fr) * 1981-10-08 1986-08-22 Aec Chim Organ Biolog Nouvelle composition pour l'enrobage des aliments et des medicaments et granules ainsi enrobes
DE3508097A1 (de) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
FR2653338B1 (fr) * 1989-10-23 1994-06-10 Dow Corning Sa Formulation pour des pansements a liberation prolongee de medicament et son utilisation.
DE4409357C2 (de) * 1994-03-18 1996-10-17 Upmeyer Hans Juergen Verwendung von Dimeticon zur Eradikation von Heliobacter pylori
CZ300696A3 (en) * 1994-03-18 1997-09-17 Alfred Schmidt USE OF DEMETICON FOR PREPARING A PHARMACEUTICAL COMPOSITION FOR LOCAL AND ANTIBACTERIAL THERAPY AND/OR PREVENTION AND THERAPY OF SYNDROMES AND INFECTIOUS DISEASES CONNECTED WITH HELIOBACTER PYLORI (Hp)
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
WO1997002019A1 (en) * 1995-06-30 1997-01-23 Baylor University Polyester/carboxylic acid composite materials
US20110039807A1 (en) * 2009-08-13 2011-02-17 Kim Hyoung-Chun Anti-parkinsonian compound acetylsalicylic acid maltol ester
WO2014014753A1 (en) * 2012-07-17 2014-01-23 Dow Global Technologies Llc Composition comprising an organic liquid diluent and a cellulose ether of very low viscosity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2805977A (en) * 1955-01-04 1957-09-10 Smith Kline French Lab Sustained release pharmaceutical preparation
GB971486A (en) * 1960-04-01 1964-09-30 Rech S Pharma Et Scient Therapeutic compositions comprising aspirin and polysiloxanes
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
AU407324B2 (en) * 1962-05-01 1970-10-28 Smith, Kline & French Laboratories Powdered silicone products and processes
US3501571A (en) * 1965-12-06 1970-03-17 Smithkline Corp Novel silicone compositions and method of preparing same
US3518344A (en) * 1967-10-02 1970-06-30 Miles Lab Tableting lubricant

Also Published As

Publication number Publication date
US3853988A (en) 1974-12-10
FR2110314A1 (OSRAM) 1972-06-02
DE2149699A1 (de) 1972-04-13
FR2110314B1 (OSRAM) 1975-06-06
GB1357737A (en) 1974-06-26
CA974883A (en) 1975-09-23
SE382560B (sv) 1976-02-09
ES395533A1 (es) 1974-10-16
DK129434C (OSRAM) 1975-03-10

Similar Documents

Publication Publication Date Title
DK129446B (da) Analogifremgangsmåde til fremstilling af fenoxyhydroxypropylaminer eller syreadditionssalte heraf.
DK124547B (da) Analogifremgangsmåde til fremstilling af (3-amino-2-hydroxy-propyloxy)-thiochromanderivater eller syreadditionssalte deraf.
DK132303C (da) Fremgangsmade til fremstilling af en legemiddelform med retarderende virkning
DK146434C (da) Fremgangsmaade til fremstilling af tabletter eller suppositorier med langvarig frigoerelse
DK131858B (da) Analogifremgangsmåde til fremstilling af 4-amino-6-arylpyrimidin-forbindelser eller syreadditionssalte deraf.
DK129434B (da) Fremgangsmåde til fremstilling af et farmaceutisk præparat af acetylsalicylsyre som virksomt stof samt polysiloxan og en celluloseæter eller ester og med gradvis frigivelse af det virksomme stof.
DK128562B (da) Fremgangsmåde til fremstilling af basiske estere af 3-methylflavon-8-carboxylsyre eller syreadditionssalte af disse estere.
DK129513B (da) Analogifremgangsmåde til fremstilling af basisk substituerede alkylidenaminooxyalkylcarboxylsyreestere eller syreadditionssalte deraf.
SE396010B (sv) Forfarande for framstellning av aktiva emnen innehallande preparat med langvarig verkan i form av tabletter, drageer eller kapslar
DK142984C (da) Analogifremgangsmaade til fremstilling af benzobicycloalkanaminer eller farmaceutisk acceptable syreadditionssalte deraf
DK139582B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive benzocycloheptaisoquinolin-forbindelser eller syreadditionssalte deraf.
DK123806B (da) Fremgangsmåde til fremstilling af tabletter eller piller med langsom afgivelse af et aktivt stof.
DK131567C (da) Analogifremgangsmade til fremstilling af 3h-1,4-benzodiazepiner eller syreadditionssalte deraf
DK129164B (da) Analogifremgangsmåde til fremstilling af 3-alkyl-5-aryloxymethylisoxazoler eller syreadditionssalte deraf.
DK138490B (da) Fremgangsmåde til fremstilling af prostadiensyrederivater.
DK134154B (da) Analogifremgangsmåde til fremstilling af 5-cyklohexyl-1-indankarboxylsyrederivater.
DK133871B (da) Fremgangsmåde til fremstilling af trans-chrysanthemsyre eller alkylestere deraf.
DK130288B (da) Analogifremgangsmåde til fremstilling af alkanolaminderivater eller syreadditionssalte deraf.
DK126424B (da) Analogifremgangsmåde til fremstilling af estere af fluocinolonacetonid.
DK127431B (da) Analogifremgangsmåde til fremstilling af thiepinderivater eller syreadditionssalte deraf.
DK137834B (da) Analogifremgangsmåde til fremstilling af triazolobenzodiazepinderivater eller syreadditionssalte deraf.
DK131623B (da) Fremgangsmåde til fremstilling af alfa-substituerede 2-aminomethyl-benzylalkoholer eller fysiologisk tålelige syreadditionssalte heraf.
DK125324B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive sulfamoylpyrimidiner.
DK129123B (da) Analogifremgangsmåde til fremstilling af 16β-karbonhydridsubstituerede estr-4-en- eller estr-5(10)-en-3-on-17β-oler eller estere eller ætere deraf.
DK129839B (da) Analogifremgangsmåde til fremstilling af N-vinylquinoloner eller syreadditionssalte deraf.